SR0079LRB103 05551 ECR 50570 r SR0079 LRB103 05551 ECR 50570 r
SR0079 LRB103 05551 ECR 50570 r
1 SENATE RESOLUTION
2 WHEREAS, Hypertrophic Cardiomyopathy (HCM) is a chronic
3 cardiovascular disease involving thickening of the heart
4 muscle and can potentially lead to debilitating symptoms and
5 serious complications, including heart failure, atrial
6 fibrillation, stroke, and, in rare cases, sudden cardiac
7 death; and
8 WHEREAS, HCM is the most common inheritable heart disease
9 and can affect anyone regardless of age, gender, or ethnicity
10 with a reported prevalence ranging from 1 in 200 to 1 in 500 in
11 the general population; and
12 WHEREAS, An estimated 700,000 to 1,650,000 people in the
13 United States have HCM, yet 85% of them may remain
14 undiagnosed; and
15 WHEREAS, HCM shares symptoms with other common
16 cardiovascular and pulmonary diseases, including shortness of
17 breath, chest pain, fatigue, palpitations, and fainting; this
18 makes it difficult to distinguish HCM from these other
19 diseases; and
20 WHEREAS, All-cause mortality risk is three to four times
21 higher in patients with HCM than that of the general
SR0079 LRB103 05551 ECR 50570 r
SR0079- 2 -LRB103 05551 ECR 50570 r SR0079 - 2 - LRB103 05551 ECR 50570 r
SR0079 - 2 - LRB103 05551 ECR 50570 r
1 population; and
2 WHEREAS, Knowing one's medical history and any signs and
3 symptoms of HCM are important first steps in receiving an
4 accurate diagnosis of HCM; and
5 WHEREAS, A healthcare provider must conduct a thorough
6 screening with cardiac health questions to help identify a
7 risk of both genetic and congenital cardiac disorders; and
8 WHEREAS, A healthcare provider may conduct several tests,
9 including an echocardiogram, a cardiac MRI, or genetic
10 testing, to confirm a family history of HCM and must examine
11 the heart to diagnose HCM; and
12 WHEREAS, Following a diagnosis of HCM, it is important for
13 patients to work with their healthcare provider to learn more
14 about their disease and understand different management
15 options, including prescription medicines and surgical
16 treatment options that may help; and
17 WHEREAS, The fourth Wednesday in February is an
18 appropriate day to observe Hypertrophic Cardiomyopathy
19 Awareness Day; therefore, be it
20 RESOLVED, BY THE SENATE OF THE ONE HUNDRED THIRD GENERAL
SR0079 - 2 - LRB103 05551 ECR 50570 r
SR0079- 3 -LRB103 05551 ECR 50570 r SR0079 - 3 - LRB103 05551 ECR 50570 r
SR0079 - 3 - LRB103 05551 ECR 50570 r
1 ASSEMBLY OF THE STATE OF ILLINOIS, that we declare February
2 22, 2023 as Hypertrophic Cardiomyopathy Awareness Day in the
3 State of Illinois in order to raise public awareness about
4 hypertrophic cardiomyopathy, a serious public health issue;
5 and be it further
6 RESOLVED, That we acknowledge the critical importance of
7 hypertrophic cardiomyopathy awareness to improve
8 cardiovascular health in the state and support raising
9 awareness of the consequences of undiagnosed and untreated
10 hypertrophic cardiomyopathy and of the need to seek
11 appropriate care for hypertrophic cardiomyopathy; and be it
12 further
13 RESOLVED, That we respectfully urge the Governor to issue
14 an annual proclamation recognizing the fourth Wednesday in
15 February as Hypertrophic Cardiomyopathy Awareness Day and call
16 upon the people of Illinois to observe the day with
17 appropriate programs and activities.
SR0079 - 3 - LRB103 05551 ECR 50570 r